A new survey from biopharmaceutical contract development and manufacturing organisation Almac Group has provided insight into how global companies are managing their clinical trial programs through the COVID-19 pandemic.
-
Industry slams last minute Trump move to cut medicine coverage
The US-based industry has slammed the former Trump administration after what was virtually its final act was to strip protections from a key government prescription benefit program meaning insurers can cut the number of medicines they cover.
-
Almac Group survey reveals pandemic impact on clinical trial activity January 22, 2021
-
Australian Biotech Bionomics-BMS combination completes trial treatment phase January 22, 2021The phase two trial involves the use of Bionomics' BNC105 in combination with Bristol Myers Squibb’s PBS-listed immunotherapy OPDIVO (nivolumab) in patients with metastatic colorectal cancer.
-
Latest News COVID-19 vaccine manufacturing, supply and administration programs January 22, 2021The speed of the US immunisation program is accelerating with the country administering 1.6 million doses in the past day. The country has now administered 19.1 million doses but it has distributed 39.9 million.
-
Latest News This is what being 'among the first in the world' looks like January 21, 2021The Australian government recently said it would 'bring forward' the country's COVID-19 immunisation program to mid-February. Yet more than 50 other countries have already launched national programs.
-
Latest News Hundreds of exemptions from active ingredient prescribing January 21, 2021Active ingredient prescribing will be introduced from 1 February but recently published guidelines suggest a complex implementation with literally hundreds of partial or complete exemptions.
-
Latest News Cystic fibrosis therapy the only one for alignment project in March January 21, 2021TRIKAFTA (elexacaftor and tezacaftor and ivacaftor) is the only submission that will be considered at the March PBAC meeting under the new pilot that is investigating greater alignment with the regulatory process.
-
Latest News Mixed news for biosimilars in April price disclosure reductions January 21, 2021The indicative price cuts for the 1 April 2021 price disclosure cycle have revealed mixed news on biosimilars with significant price cuts but only after several years.
-
Latest News Over 20 MS projects funded under new round of grants January 21, 2021Twenty research projects focused on multiple sclerosis will receive a total of $2.9 million in grants under a program run by MS Research Australia and MS Australia.
-
Latest News Queensland research institute in new cell therapy trial January 21, 2021Researchers at the QIMR Berghofer Medical Research Institute in Brisbane have launched a clinical trial of a new cellular immunotherapy treatment.
-
Latest News BioPharmaDispatch conference returns to May with a focus on 'challenges' January 20, 2021The day's theme is 'challenges' against the backdrop of COVID-19, the 2021-22 Budget and the renegotiation of the federal government's existing industry agreements.
-
Latest News Investors back Chimeric Therapeutics on ASX debut January 20, 2021A strong debut on the ASX for Chimeric Therapeutics with investors backing the company that is focused on the development of CAR-T cell therapies for solid tumours.
-
Latest News Winners of the CSANZ-Bayer young investigator research grants January 20, 2021Bayer has marked its third year in partnership with the Cardiac Society of Australia and New Zealand by announcing the winners of the 2020 CSANZ-Bayer Young Investigator Research Grants.
-
Latest News The shocking double standard means no more lectures on transparency January 19, 2021When it comes to confidentiality and transparency, there is one rule for pharmaceutical companies and another for the Department of Health and the organisations it chooses to protect.
Latest Video
New Stories
-
COVID-19 vaccine manufacturing, supply and administration programs
January 22, 2021 - - Latest News -
Bionomics-BMS combination completes trial treatment phase
January 22, 2021 - - Australian Biotech -
Almac Group survey reveals pandemic impact on clinical trial activity
January 22, 2021 - -
Industry slams last minute Trump move to cut medicine coverage
January 22, 2021 - -
Queensland research institute in new cell therapy trial
January 21, 2021 - - Latest News -
This is what being 'among the first in the world' looks like
January 21, 2021 - - Latest News -
Hundreds of exemptions from active ingredient prescribing
January 21, 2021 - - Latest News